Ignite Creation Date:
2025-12-25 @ 12:07 AM
Ignite Modification Date:
2026-02-26 @ 12:40 AM
Study NCT ID:
NCT06897358
Status:
RECRUITING
Last Update Posted:
2025-10-15
First Post:
2025-03-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Leniolisib for Immune Dysregulation in CVID
Sponsor:
Pharming Technologies B.V.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LE 8201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |